» Articles » PMID: 22365606

Rational Design of Small Molecule Inhibitors Targeting the Rac GTPase-p67(phox) Signaling Axis in Inflammation

Overview
Journal Chem Biol
Publisher Elsevier
Date 2012 Feb 28
PMID 22365606
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The NADPH oxidase enzyme complex, NOX2, is responsible for reactive oxygen species production in neutrophils and has been recognized as a key mediator of inflammation. Here, we have performed rational design and in silico screen to identify a small molecule inhibitor, Phox-I1, targeting the interactive site of p67(phox) with Rac GTPase, which is a necessary step of the signaling leading to NOX2 activation. Phox-I1 binds to p67(phox) with a submicromolar affinity and abrogates Rac1 binding and is effective in inhibiting NOX2-mediated superoxide production dose-dependently in human and murine neutrophils without detectable toxicity. Medicinal chemistry characterizations have yielded promising analogs and initial information of the structure-activity relationship of Phox-I1. Our studies suggest the potential utility of Phox-I class inhibitors in NOX2 oxidase inhibition and present an application of rational targeting of a small GTPase-effector interface.

Citing Articles

Reactive oxygen species: Orchestrating the delicate dance of platelet life and death.

Liao R, Wang L, Zeng J, Tang X, Huang M, Kantawong F Redox Biol. 2025; 80:103489.

PMID: 39764976 PMC: 11759559. DOI: 10.1016/j.redox.2025.103489.


NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors.

Cipriano A, Viviano M, Feoli A, Milite C, Sarno G, Castellano S J Med Chem. 2023; 66(17):11632-11655.

PMID: 37650225 PMC: 10510401. DOI: 10.1021/acs.jmedchem.3c00770.


Structure, Activation, and Regulation of NOX2: At the Crossroad between the Innate Immunity and Oxidative Stress-Mediated Pathologies.

Nocella C, DAmico A, Cammisotto V, Bartimoccia S, Castellani V, Loffredo L Antioxidants (Basel). 2023; 12(2).

PMID: 36829988 PMC: 9952346. DOI: 10.3390/antiox12020429.


NADPH oxidase family proteins: signaling dynamics to disease management.

Begum R, Thota S, Abdulkadir A, Kaur G, Bagam P, Batra S Cell Mol Immunol. 2022; 19(6):660-686.

PMID: 35585127 PMC: 9151672. DOI: 10.1038/s41423-022-00858-1.


RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma.

Colon-Bolea P, Garcia-Gomez R, Casar B Biomolecules. 2021; 11(11).

PMID: 34827551 PMC: 8615836. DOI: 10.3390/biom11111554.


References
1.
Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I . N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial. Biol Psychiatry. 2008; 64(6):468-75. DOI: 10.1016/j.biopsych.2008.04.022. View

2.
Jaquet V, Scapozza L, Clark R, Krause K, Lambeth J . Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid Redox Signal. 2009; 11(10):2535-52. DOI: 10.1089/ars.2009.2585. View

3.
Perisic O, Wilson M, Karathanassis D, Bravo J, Pacold M, Ellson C . The role of phosphoinositides and phosphorylation in regulation of NADPH oxidase. Adv Enzyme Regul. 2004; 44:279-98. DOI: 10.1016/j.advenzreg.2003.11.003. View

4.
Bosco E, Mulloy J, Zheng Y . Rac1 GTPase: a "Rac" of all trades. Cell Mol Life Sci. 2009; 66(3):370-4. PMC: 6669905. DOI: 10.1007/s00018-008-8552-x. View

5.
Bokoch G, Diebold B . Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood. 2002; 100(8):2692-6. DOI: 10.1182/blood-2002-04-1149. View